SBH
WST icon

Segall Bryant & Hamill’s West Pharmaceutical WST Stock Holding History

Segall Bryant & Hamill’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,132
Closed -$593K – 562
2014
Q4 		$593K Buy
11,132
+2,680
+32% +$134K 0.01% 403
2014
Q3 		$378K Buy
+8,452
New +$359K 0.01% 462

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Segall Bryant & Hamill's WST Position: Q1 2015 in Review

Segall Bryant & Hamill sold out of West Pharmaceutical (WST) in Q1 2015, closing a stake of 11,132 shares — an estimated $593K sold.

Segall Bryant & Hamill first reported a position in WST in Q3 2014 and held it in 2 quarters. The position peaked at $593K in Q4 2014. 214 funds tracked by Wall St. Rank hold WST as of Q1 2015.

  • Segall Bryant & Hamill reported no remaining West Pharmaceutical position as of Q1 2015 after selling out during the quarter.
  • Segall Bryant & Hamill sold 11,132 West Pharmaceutical shares in Q1 2015, an estimated $593K.
  • Segall Bryant & Hamill first reported a position in West Pharmaceutical in Q3 2014 and held it in 2 quarters.
  • Segall Bryant & Hamill's West Pharmaceutical position peaked at $593K in Q4 2014.
  • 214 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2015.

Based on Segall Bryant & Hamill's 13F filing for Q1 2015, filed 14 May 2015.